Helen Knight, director of medicines evaluation at NICE, said: Our committee recognised the potential tirzepatide has to provide an effective and good value treatment option for all those living with poorly controlled type 2 diabetes. Poorly controlled type 2 diabetes, with its associated additional health risks, is a huge challenge for those living with the condition and the NHS. This summer it was reported that patients with type 2 diabetes on semaglutide and other glucagon-like peptide-1 receptor agonists (GLP-1 RA) drugs are having to stop taking them, amidst ongoing shortages
Dikoma Shungu has been pivotal
& Sanderson, P
The antidepressant sertraline provides a novel host directed therapy module for augmenting TB therapy
We use cookies that are necessary for the smooth operation of the website, to improve our website and to display advertising relevant to you on social media platforms and partner websites.By clicking "Accept all", you agree to the use of cookies for convenience features and statistics and tracking.You can change these settings again at any time.If you do not agree, we will limit ourselves to technically necessary cookies
While the direct impact of glutathione supplements on cancer remains under study, obtaining glutathione from dietary sources is encouraged as part of a balanced diet